Thursday Jul 17
Nuvilex and Austrianova Announce Results of Clinical Trial in Dogs...
These results were published in the . Sixteen female dogs were enrolled in the clinical trial.
Nuvilex Provides Shareholder Update on Milestone Accomplishments
Dear Nuvilex Shareholders, First and foremost, on behalf of the entire Nuvilex Management Team we wish to thank you for your continued support.
Nuvilex Scheduled To Begin Preclinical Studies In Early August
Nuvilex, Inc. , a clinical-stage international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, announced today that all preparations for the commencement of its preclinical studies to determine the effectiveness of Nuvilex's pancreatic cancer treatment in slowing down the accumulation of ascites fluid ... (more)
Nuvilex Heads To The Clinic With An Opportunity To Treat A Wider Range Of Cancers
Nuvilex, Inc. and its shareholders should soon experience an event that, to date, has not been enjoyed by the Maryland biotech firm.